Arlene Morris, Director at Cogent Biosciences, Inc. (COGT), sold 45,510 shares at $37.09 ($1.7M) on 2026-08-27, disclosed to the SEC on 2026-08-31.
Scheduled sale ($1.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.09 | 42,349 | $1.6M | 93.0% |
| 2 | $37.54 | 3,161 | $119K | 7.0% |
| Total | $37.12 avg | 45,510 | $1.7M | 100% |
| Filing → |
| AFFY | SELL | 2010-05-19 | $1.3M | — | Filing → |
| AFFY | SELL | 2010-05-13 | $4.6M | — | Filing → |
| AFFY | SELL | 2010-04-26 | $8K | — | Filing → |